BellBrook Labs, LLC develops detection reagents and microfluidic devices that accelerate the discovery of more effective therapies for cancer and other debilitating diseases. Transcreener is a patented high throughput screening assay platform used to identify inhibitors for kinases and other types of protein drug targets. The iuvo Microconduit Array technology is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.
Recent Posts
- US takes another look at recycling nuclear fuel
- Madison startup Nurse Disrupted provides crucial virtual health care
- SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
- Midwest Games Raises $3 Million With Green Bay Packers, Microsoft VC
- Fetch Announces Former Uber Executive as New Chief Financial Officer
Archives
- February 2024
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- December 2022
- October 2022
- August 2022
- December 2020
- November 2020
- October 2020
- September 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- February 2018
- September 2017
Categories
- Active Portfolio Companies
- Agricycle
- AIQ Solutions
- Aver
- Curate Solutions
- EnsoData
- FetchRewards
- Flugen
- gener8tor
- HealthMyne
- Imbed Biosciences
- Invenra
- Kiio
- Midwest Games
- News
- Nurse Disrupted
- OnLume
- Phoenix
- POPS
- Pyran
- SHINE
- Silatronix
- SimpleMachines
- Stemina
- Stratatech
- Swallow Solutions
- TAI Diagnostics
- Vint
Recent Comments